Dna X (SONM) Total Current Liabilities (2018 - 2026)

Dna X's Total Current Liabilities history runs 9 years deep, the most recent figure standing at $4.3 million for Q1 2026.

• Quarterly Total Current Liabilities fell 87.54% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (down 87.54% YoY) and the FY2025 annual result came in at $50.6 million, up 15.74% from the prior year.
• Total Current Liabilities was $4.3 million for Q1 2026 at Dna X, down from $50.6 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $50.6 million in Q4 2025 and bottomed at $4.3 million in Q1 2026.
• A 5-year average of $30.8 million and a median of $32.1 million in 2022 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2025 — Total Current Liabilities surged 65.33% — and 2026, when it sank 87.54%.
• Dna X's Total Current Liabilities stood at $32.1 million in 2022, then rose by 0.27% to $32.1 million in 2023, then soared by 36.06% to $43.7 million in 2024, then advanced by 15.74% to $50.6 million in 2025, then slumped by 91.46% to $4.3 million in 2026.
• Business Quant data shows SONM's Total Current Liabilities at $4.3 million in Q1 2026, $50.6 million in Q4 2025, and $38.9 million in Q3 2025.